Viemed Healthcare, Inc. cash flow statement VMD

Annual Quarterly

In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, Viemed Healthcare, Inc. generated $11.5 million of cash from operations, down 37.5% from the same quarter a year earlier. It spent $8.6 million on capital expenditures. That left free cash flow of $2.9 million. The company returned $977,000 in share buybacks to shareholders.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the same quarter a year earlier.

TTM
Sep 30, 2026
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Operating
Depreciation and amortization
30
+11.0%
8
+2.4%
8
+9.1%
8
+15.2%
8
+18.9%
8
+17.6%
7
+9.2%
7
+5.2%
6
Stock-based compensation
9
+10.8%
2
+13.6%
2
-13.2%
2
+6.1%
2
+51.2%
2
+27.3%
2
+44.5%
2
+61.4%
2
-0.8%
Operating cash flow
54
+11.2%
11
-37.5%
16
+29.8%
8
+182.8%
18
+23.0%
18
+44.1%
12
+20.3%
3
+142.9%
15
+12.8%
Investing
Capital expenditures
33
-24.5%
9
+12.8%
8
+4.1%
7
-56.6%
9
-26.1%
8
-30.6%
8
-9.0%
15
+157.8%
12
+49.1%
Investing cash flow
-28
+45.1%
-7
+76.9%
-8
-353.9%
-5
+35.7%
-8
+17.2%
-32
-550.0%
-2
+84.5%
-9
-59.0%
-9
-22.8%
Financing
Stock buybacks
8
1
-91.5%
5
+219.8%
1
0
12
2
—
—
Financing cash flow
-27
-979.0%
-5
-199.8%
-7
-965.0%
-6
-271.2%
-8
-2191.8%
5
+196.2%
-1
-127.0%
-2
-27.2%
0
+113.3%
Change in cash
Net change in cash
-1
-546.0%
-1
+88.7%
1
-90.7%
-4
+49.3%
2
-61.6%
-9
-450.1%
10
+557.9%
-7
-33.5%
6
+124.3%
Free cash flow
21
+297.0%
3
-73.2%
7
+80.4%
1
+110.8%
10
+207.3%
11
+515.7%
4
+230.5%
-13
-161.4%
3
-41.0%
Per share
Free cash flow per share
0.52
+300.4%
0.07
-73.7%
0.18
+80.2%
0.03
+111.1%
0.24
+215.4%
0.26
+520.0%
0.10
+226.3%
-0.30
-154.8%
0.08
-42.1%
Shareholder returns
Returned to shareholders
8
1
5
1
0
12
2
—
—
Share of free cash flow
36.20%
34.03%
71.51%
105.89%
0.00%
107.73%
40.34%
—
—
Ratios
Free cash flow margin
6.89%
3.56%
9.53%
1.80%
12.74%
14.92%
6.54%
-21.36%
5.20%
Capital expenditures to revenue
10.48%
10.68%
10.83%
8.90%
11.47%
10.62%
12.89%
26.19%
19.49%
Stock-based compensation to revenue
2.98%
3.07%
2.60%
3.25%
3.02%
3.03%
3.71%
3.91%
2.51%
Cash conversion
3.45x
2.48x
5.75x
3.13x
3.27x
5.23x
3.88x
1.09x
3.47x
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
VMD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Lafayette, LA
SEC filer status
Accelerated filer
SEC CIK
1729149

Other Services-Misc Health & Allied Services, NEC companies

All 15 Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.